Website
News25/Ratings12
News · 26 weeks85+23%
2025-10-262026-04-19
Mix3590d
- Insider24(69%)
- SEC Filings5(14%)
- Earnings3(9%)
- Other3(9%)
Latest news
25 items- INSIDERDirector Pellegrino Joseph P Jr exercised 2,941 shares at a strike of $35.48, increasing direct ownership by 24% to 15,021 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- PRLeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of pe
- SECSEC Form DEFA14A filed by LeMaitre Vascular Inc.DEFA14A - LEMAITRE VASCULAR INC (0001158895) (Filer)
- SECSEC Form DEF 14A filed by LeMaitre Vascular Inc.DEF 14A - LEMAITRE VASCULAR INC (0001158895) (Filer)
- SECLeMaitre Vascular Inc. filed SEC Form 8-K: Leadership Update8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
- PRLeMaitre to Present at the 25th Annual Needham Virtual Healthcare ConferenceBURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2025, at 2:15 PM EDT. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-42
- INSIDERSEC Form 4 filed by Shadan Martha4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Ross Bridget A4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by O'Connor John James4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Roush John A4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Jasinski Lawrence J4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Pellegrino Joseph P Jr4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Roberts David B4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Kamke Trent G4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Leblanc Dorian Paul4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Lemaitre George W4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by LeMaitre Vascular Inc.SCHEDULE 13G/A - LEMAITRE VASCULAR INC (0001158895) (Subject)
- INSIDERSenior V. P., Operations Kamke Trent G exercised 2,625 shares at a strike of $35.48 and sold $284,812 worth of shares (2,625 units at $108.50) (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERPresident and Director Roberts David B sold $356,586 worth of shares (3,312 units at $107.68), decreasing direct ownership by 18% to 14,667 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERChief Financial Officer Leblanc Dorian Paul converted options into 2 shares and covered exercise/tax liability with 96 shares, decreasing direct ownership by 4% to 2,302 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector Shadan Martha was granted 476 shares and converted options into 1 shares, increasing direct ownership by 19% to 2,962 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector Roush John A was granted 476 shares and converted options into 1 shares, increasing direct ownership by 14% to 3,942 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector Ross Bridget A was granted 476 shares and converted options into 1 shares, increasing direct ownership by 14% to 3,942 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector O'Connor John James was granted 476 shares and converted options into 1 shares, increasing direct ownership by 0.77% to 62,827 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector Jasinski Lawrence J was granted 476 shares and converted options into 1 shares, increasing direct ownership by 9% to 5,799 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)